June 8, 2023
Rashmin Savani, MBChB, Head of Scientific Advisory Board, Azome Therapeutics, presented results of preclinical research supporting the company’s RHAMM (Receptor for Hyaluronan-Mediated Motility) antagonist technology platform at the 14th conference of the International Society for Hyaluronan Sciences held this week in Portland, Oregon.